Related by context. All words. (Click for frequent words.) 67 Taxotere ® 67 TORISEL 66 REVLIMID ® 65 VIDAZA 65 Torisel 64 VELCADE 64 MabThera 64 lenalidomide 64 clofarabine 64 Amrubicin 64 HUMIRA 64 CoFactor 64 SUTENT 64 TEMODAL 63 REVLIMID lenalidomide 63 sunitinib 63 PROMACTA 63 Jevtana 63 Revlimid 63 Fludara 63 FOLOTYN 63 Revlimid lenalidomide 63 axitinib 63 Clolar 62 VPRIV 62 Taxotere R 62 bendamustine 62 pomalidomide 62 romiplostim 62 amrubicin 62 temozolomide 62 IMiDs 62 REVLIMID R 62 Certican 62 COPAXONE ® 62 TREANDA 62 YONDELIS 62 monotherapy 62 Vectibix 62 Tarceva 61 XGEVA 61 TYKERB 61 pemetrexed 61 COPAXONE R 61 perifosine 61 ABRAXANE 61 low dose dexamethasone 61 THALOMID 61 relapsed refractory multiple myeloma 61 Cimzia ® 61 ORENCIA R 61 azacitidine 61 HER2 positive metastatic breast 61 ACTEMRA 61 Azedra 61 ERBITUX 61 Vidaza 61 Rituximab 61 indolent NHL 61 vandetanib 61 Marqibo 61 Pixantrone 60 IRESSA 60 metastatic renal cell carcinoma 60 IMiDs ® compound 60 enzastaurin 60 Hycamtin 60 sunitinib malate 60 docetaxel Taxotere R 60 ofatumumab 60 RoACTEMRA 60 plus dexamethasone 60 Raptiva ® 60 Avastin bevacizumab 60 relapsed refractory 60 bevacizumab 60 YERVOY 60 abatacept 60 T DM1 60 temsirolimus 60 Tarceva TM 60 Mimpara 60 Nplate 60 erlotinib 60 decitabine 60 standard chemotherapy regimen 60 biologic therapy 60 relapsed multiple myeloma 60 rituximab 59 IMGN# 59 Nexavar 59 NOXAFIL 59 dacarbazine 59 Ilaris 59 Traficet EN 59 mRCC 59 Evoltra TM 59 DOXIL 59 Dacogen injection 59 Treanda 59 sorafenib tablets 59 tocilizumab 59 MabCampath 59 CYT# 59 EOquin TM 59 Multaq R 59 HuMax CD4 59 vinorelbine 59 orphan designation 59 Pemetrexed 59 ixabepilone 59 pegfilgrastim 59 panitumumab 59 Evoltra ® 59 Pirfenidone 59 pertuzumab 59 Pazopanib 59 tesmilifene 59 registrational 59 Virulizin R 59 Bronchitol 59 bortezomib Velcade 59 carfilzomib 59 FUZEON 59 AVASTIN 59 trabectedin 59 pitavastatin 59 Mylotarg 59 Halaven 59 Ventavis 59 STELARA 59 Navelbine ® 59 capecitabine 59 Satraplatin 59 Neulasta ® 59 everolimus 59 dasatinib 59 Actemra 58 Velcade bortezomib 58 Perifosine 58 lapatinib 58 Targretin 58 Bevacizumab 58 docetaxel 58 ISENTRESS 58 Vandetanib 58 Tarceva erlotinib 58 Aclasta 58 IMiDs R 58 Angiox 58 fenofibrate 58 ATryn R 58 Herceptin trastuzumab 58 metastatic colorectal cancer 58 sorafenib 58 FOLOTYN ® 58 REMICADE ® 58 SIMPONI 58 entecavir 58 Rituxan 58 OPAXIO 58 Nexavar ® 58 FTY# 58 Evoltra 58 HGS# 58 rFIXFc 58 docetaxel Taxotere ® 58 elotuzumab 58 Clolar ® 58 Cimzia 58 Betaferon ® 58 Azilect ® 58 Noxafil 58 pixantrone 58 ZOLINZA 58 chronic lymphocytic leukemia CLL 58 sorafenib Nexavar 58 BARACLUDE R 58 Cladribine Tablets 58 FAMPYRA 58 oral anticoagulant 58 Glivec 58 ACTEMRA TM 58 Ixempra 58 Rituxan rituximab 58 Nimotuzumab 58 Angiox R 58 topotecan 58 ZADAXIN ® 58 GvHD 58 SEROQUEL 58 Alimta 57 Afinitor 57 ACZ# 57 Cimzia ® certolizumab pegol 57 Genasense 57 satraplatin 57 ADVEXIN 57 Femara 57 FOSRENOL 57 ZEVALIN 57 SEBIVO 57 Ceftobiprole 57 lupus nephritis 57 oral ridaforolimus 57 SPRYCEL 57 paclitaxel Taxol ® 57 Telavancin 57 ONTAK 57 CellCept 57 Icatibant 57 gemcitabine 57 mitoxantrone 57 Tavocept 57 JANUVIA 57 CIMZIA TM 57 CHOP chemotherapy 57 MOZOBIL 57 Loramyc ® 57 eltrombopag 57 infusional 5-FU/LV 57 Taxotere 57 advanced NSCLC 57 Certolizumab pegol 57 Advagraf 57 Bendamustine 57 EFAPROXYN 57 alvimopan 57 Allovectin 7 ® 57 adalimumab 57 imatinib 57 MGCD# [001] 57 Xcytrin 57 cetuximab 57 Hepsera 57 heavily pretreated 57 Vfend 57 vidofludimus 57 TRISENOX 57 COMFORT II 57 Cimzia R 57 BEXXAR 57 picoplatin 57 Naglazyme 57 Clevudine 57 Firazyr 57 docetaxel Taxotere 57 tolerability profile 57 Gemzar ® 57 REYATAZ R 57 Catena ® 57 mycophenolate mofetil 57 Mitoxantrone 57 bevacizumab Avastin 57 Actemra tocilizumab 57 panitumumab Vectibix 57 non metastatic osteosarcoma 57 Everolimus 57 investigational compound 57 Irinotecan 57 immunosuppressant 57 abiraterone acetate 57 everolimus tablets 57 evaluating REVLIMID 57 Tracleer R 57 INCB# [002] 57 Keppra ® 57 OHR/AVR# 56 TREDAPTIVE 56 Golimumab 56 mTOR inhibitor 56 Eltrombopag 56 xanthine oxidase inhibitor 56 MYLOTARG 56 Abraxane 56 ARIKACE 56 Rebif ® 56 ZADAXIN 56 Doxil 56 phase IIb clinical 56 liposomal formulation 56 Ceplene 56 AZILECT ® 56 Carboplatin 56 dexamethasone 56 PROCHYMAL 56 sapacitabine 56 cetuximab Erbitux ® 56 fidaxomicin 56 daclizumab 56 pegylated liposomal doxorubicin 56 Taxotere docetaxel 56 galiximab 56 Lenalidomide 56 Fludara ® 56 INTELENCE 56 FOLFIRI 56 ProLindac 56 Dacogen 56 randomized Phase III 56 letrozole Femara 56 eculizumab 56 Gemcitabine 56 Betaferon 56 Exjade 56 pancreatic NET 56 Filgrastim 56 obatoclax 56 carboplatin 56 gefitinib 56 Valsartan 56 TYZEKA 56 Carfilzomib 56 NEUPOGEN 56 Ceflatonin 56 telbivudine 56 AVONEX 56 mapatumumab 56 HER2 positive breast cancer 56 DORIBAX 56 Alvesco R 56 Revimmune 56 ceftaroline 56 Afinitor ® 56 refractory chronic lymphocytic 56 oral FTY# 56 nab paclitaxel 56 CAELYX 56 Cloretazine 56 ORENCIA ® 56 Gleevec Glivec 56 Adalimumab 56 TYGACIL 56 FIRAZYR 56 dosing regimens 56 liposomal doxorubicin 56 forodesine 56 denosumab 56 trastuzumab 56 L MTP PE 56 Ranexa 56 NEBIDO 56 Tygacil 56 Leukine 56 rilonacept 56 Defibrotide 56 PXD# 56 chlorambucil 56 Thalidomide Pharmion 56 SNT MC# 56 adalimumab Humira 56 deforolimus 56 tipranavir 56 XL# [003] 56 Kuvan 56 TELINTRA 56 tanespimycin 56 ThermoDox ® 56 bone metastases 56 fondaparinux 56 IMA# 56 tamibarotene 56 temsirolimus Torisel ® 56 custirsen 56 Cimzia TM 56 paclitaxel Taxol 56 Medicinal Products EMEA 56 SJIA 56 XELOX 56 Ribavirin 56 JAK inhibitor 56 anti leukemic 56 Phase Ib 56 thalidomide Thalomid 56 Phase IIIb clinical 56 nilotinib 56 tigecycline 56 dose dexamethasone 56 cutaneous T cell 56 ZENPEP 56 ZYVOX 56 antitumor activity 56 regorafenib 56 gemcitabine chemotherapy 56 zalutumumab 56 Azixa 56 Loramyc R 56 adult chronic ITP 55 ONGLYZA ™ 55 angiogenesis inhibitor 55 etanercept 55 Ceplene R 55 Plenaxis R 55 Avastin 55 Eloxatin R 55 multiple myeloma MM 55 Yondelis ® 55 crizotinib PF # 55 APTIVUS 55 FACTIVE 55 Mozobil 55 posaconazole 55 Increlex ® 55 Pertuzumab 55 CIMZIA 55 VIBATIV 55 Azacitidine 55 natalizumab 55 SUTENT ® 55 relapsing multiple sclerosis 55 Velcade 55 iniparib 55 Promacta 55 metastatic hormone refractory 55 Virulizin ® 55 VELCADE melphalan 55 dirucotide 55 Erlotinib 55 ustekinumab 55 Orphan Drug designation 55 glatiramer acetate 55 ONCASPAR 55 Marketing Authorization Application 55 ELOXATIN 55 Erbitux 55 Kepivance 55 methotrexate MTX 55 Natalizumab 55 refractory CTCL 55 pazopanib 55 FOSRENOL R 55 omacetaxine 55 ezogabine 55 Phase 2b clinical 55 AZILECT R 55 REPLAGAL 55 chronic ITP 55 CLL8 55 bazedoxifene 55 DASISION 55 Nexavar sorafenib 55 BENLYSTA 55 Paraplatin ® 55 oral formulation 55 follicular NHL 55 ganetespib 55 epratuzumab 55 GTC recombinant human 55 Degarelix 55 Dasatinib 55 chemotherapy regimens 55 Bezielle 55 hematologic malignancies 55 Betaferon R 55 chronic angina 55 protease inhibitor PI 55 alefacept 55 PEGINTRON 55 BAY #-# 55 interferon gamma 1b 55 relapsed SCLC 55 B CLL 55 ponatinib 55 thymalfasin 55 MabThera Rituxan 55 Soliris 55 MYCAMINE 55 cytarabine 55 interferon beta 1b 55 5 FU 55 Romiplostim 55 LymphoStat B 55 mycophenolate mofetil MMF 55 fluoropyrimidine 55 entinostat 55 Targretin capsules 55 MabThera rituximab 55 Trastuzumab 55 oxaliplatin Eloxatin 55 Genasense ® 55 Perforomist TM Inhalation Solution 55 lintuzumab 55 pegylated interferon 55 BRAF inhibitor 55 maribavir 55 relapsed ovarian cancer 55 Femara letrozole 55 Cloretazine R VNP#M 55 tolerability 55 ASA# 55 Levulan PDT 55 ThermoDox R 55 Tasigna 55 pulmonary arterial hypertension 55 vorinostat 55 melphalan prednisone 55 Sandostatin LAR 55 Sebivo 55 BARACLUDE ® 55 Newly Diagnosed Multiple Myeloma 55 carboplatin paclitaxel 55 peginterferon alfa 2a 55 Raptiva R 55 Mipomersen 55 superficial bladder cancer 55 Elidel 55 Tasigna nilotinib 55 receptor tyrosine kinase inhibitor 55 Clofarabine 55 velaglucerase alfa 55 Docetaxel 55 refractory multiple myeloma 55 FOLFOX4 55 AP# [003] 55 veltuzumab 55 aflibercept 55 ENBREL 55 TNFerade 55 pegylated interferon alfa 55 Imprime PGG 55 PEG INTRON 55 Rituxan MabThera 55 Synvisc One 55 HRPC 55 GARDASIL 55 brentuximab vedotin 55 Loramyc 55 teduglutide 55 oral iron chelator 55 nucleoside analogs 55 angiotensin II receptor blocker 55 Xeloda ® 55 lapatinib Tykerb 55 TYSABRI 55 taxane 55 Oxaliplatin 55 oral antiviral 54 low dose cytarabine 54 oropharyngeal candidiasis 54 RAPTIVA 54 palifosfamide 54 Arixtra 54 Phase Ib II 54 CYPHER ® Stent 54 Civacir 54 bevacizumab Avastin ® 54 angiotensin receptor blocker ARB 54 Cytoxan 54 Bortezomib 54 BRIM2 54 Mycamine 54 OMAPRO 54 Kit CD# positive 54 chronic ITP patients 54 CD# antibody [001] 54 Onrigin 54 Alitretinoin 54 fluvastatin 54 MEPACT 54 BiovaxID 54 G CSF 54 LIALDA 54 Prochymal 54 zoledronic acid 54 RAPAFLO 54 reslizumab 54 dose cohorts 54 rFVIIa 54 OncoVEX GM CSF 54 chemotherapeutic agent 54 SPRYCEL ® 54 Yondelis 54 SEROQUEL XR 54 Phase 1b 54 Retacrit 54 Cloretazine ® 54 Increlex R 54 R sorafenib tablets 54 gastrointestinal stromal tumors GIST 54 DMARD 54 Vidaza R 54 atacicept 54 Arranon 54 belinostat 54 dosage regimens 54 Phenoptin 54 Teysuno 54 Rifaximin 54 ONGLYZA 54 Zavesca ® 54 relapsed MM 54 albinterferon alfa 2b 54 NXL# 54 leukemia CLL 54 registrational studies 54 NSCLC 54 MBP# [001] 54 IMiDs ® 54 Tamibarotene 54 direct renin inhibitor 54 Lodotra 54 FASLODEX 54 neratinib 54 diagnosed multiple myeloma 54 Pfizer Sutent 54 Cinryze 54 Dacogen decitabine 54 TELCYTA 54 vosaroxin 54 bortezomib 54 HuMax EGFr 54 Cetuximab Erbitux 54 Octreotide 54 chemotherapy regimen 54 Zarnestra 54 MuGard 54 DMARDs 54 teriflunomide 54 Fludarabine 54 lenalidomide Revlimid R 54 eribulin 54 TroVax ® 54 glufosfamide 54 Lialda 54 Emselex 54 histone deacetylase HDAC inhibitor 54 Aplidin 54 cSSSI 54 silodosin 54 lumiliximab 54 hematological malignancies 54 anti TNF 54 Ceftaroline 54 celgosivir 54 Peg IFN 54 rFVIIIFc 54 blinatumomab 54 maraviroc 54 anti angiogenic therapy 54 olmesartan 54 ARIXTRA 54 boosted protease inhibitor 54 methylnaltrexone 54 Alocrest 54 SYMBICORT 54 rNAPc2 54 indacaterol 54 canakinumab 54 recurrent ovarian cancer 54 Multiferon R 54 dasatinib Sprycel ® 54 LEUKINE 54 ATL# [001] 54 ONCONASE 54 Chemophase 54 multi kinase inhibitor 54 Taxol paclitaxel 54 Phase 2b trial 54 Laquinimod 54 Toctino R 54 alvespimycin 54 GI GVHD 54 phase IIa clinical 54 Gleevec imatinib mesylate 54 bicalutamide 54 talactoferrin 54 imetelstat 54 Sorafenib 54 Hycamtin ® 54 docetaxel chemotherapy 54 Octreolin 54 TheraCIM 54 Zolinza 54 TAXOTERE R 54 EGFR expressing mCRC 54 Aptivus ® 54 Evoltra R 54 Orphan Designation 54 dirucotide MBP# 54 Gemzar 54 CA4P 54 Elagolix 54 Abiraterone acetate 54 CANCIDAS 54 elacytarabine 54 eniluracil 54 heavily pretreated patients 54 Phase 1b trial 54 desvenlafaxine 54 #D#C# 54 Advexin 54 ThermoDox 54 Exforge 54 Alpharadin 54 Epratuzumab 54 CIMZIA ™ 54 Cladribine tablets 54 XIENCE V 54 cisplatin chemotherapy 54 febuxostat 54 Darunavir 54 Ceplene/IL-2 54 dabigatran etexilate 54 oral deforolimus 54 omalizumab 54 anastrozole 54 FOLFOX 54 Marketing Authorisation Application 54 relapsing remitting multiple sclerosis 54 Tekturna 54 Virulizin 54 investigational drug 54 surrogate endpoint 54 anticancer therapies 54 Alkeran 54 anticancer therapy 54 palonosetron 54 Rasagiline 54 follicular lymphoma FL 54 voreloxin 54 AVONEX ® 54 cilengitide 54 Sutent sunitinib 54 Protelos 54 Alemtuzumab 54 ANTEGREN 54 mCRC patients 54 fluorouracil 54 nitazoxanide 54 ® lenalidomide 54 peg IFN 54 SYCREST 54 Azilect 54 Urocidin 54 pralatrexate 54 PhosLo 54 Orazol 54 Onco TCS 54 lomitapide 54 vemurafenib 54 Prexige 54 erlotinib Tarceva ® 54 anticancer agent 54 ZOSTAVAX 54 Tekturna HCT 54 refractory CLL 54 AGGRASTAT ® 53 hormone refractory prostate cancer 53 OMP designation 53 aliskiren 53 Aryplase 53 Amigal 53 sorafenib Nexavar ® 53 Phase Ib study 53 invasive fungal infections 53 Peginterferon alfa 2b 53 estramustine 53 quinolone 53 Phase III clinical 53 Augment Injectable 53 topical NSAID 53 tacrolimus 53 XIFAXAN 53 NeoVisc 53 Ambrisentan 53 irinotecan 53 subcutaneous formulation 53 pulmonary arterial hypertension PAH 53 Epoetin alfa 53 CYCLOSET 53 Nivestim 53 mCRC 53 Erbitux cetuximab 53 Baraclude 53 Navelbine 53 Denosumab 53 FROVA 53 solid tumors 53 follicular lymphoma 53 BYETTA ® 53 Amplimexon 53 registrational trial 53 Locteron 53 StaphVAX 53 pegylated interferon alpha 53 DAVANAT R 53 RG# [001] 53 FUSILEV 53 fludarabine 53 Aptivus 53 Maraviroc 53 miconazole Lauriad ® 53 infliximab 53 lacosamide 53 Xanafide 53 AEGR 53 Lapatinib 53 oral mucositis 53 octreotide implant 53 VALSTAR 53 lenalidomide dexamethasone 53 alfa 2a 53 herpetic keratitis 53 budesonide 53 trastuzumab Herceptin 53 investigational antiplatelet agent 53 anakinra 53 cabazitaxel 53 GAMMAGARD 53 taxanes 53 acyclovir Lauriad R 53 trabedersen 53 anidulafungin 53 plus gemcitabine 53 Mepact 53 certolizumab pegol 53 granisetron 53 calcineurin inhibitors 53 Phase 2a trial 53 cetuximab Erbitux 53 motavizumab 53 tyrosine kinase inhibitor 53 Xeloda 53 Etanercept 53 dose escalation clinical 53 Maribavir 53 refractory metastatic colorectal cancer 53 Doxil ® 53 tiotropium 53 Gleevec imatinib 53 Boceprevir 53 metastatic breast cancer 53 dose escalation 53 Vaprisol 53 ROTATEQ 53 CLARITY study 53 Phase Ib clinical 53 INC# 53 XmAb# 53 Rhucin 53 xenograft models 53 oncology indications 53 Yervoy 53 Temozolomide 53 Onconase 53 Pegasys ® 53 Neupogen ® 53 acute coronary syndromes ACS 53 Vicinium TM 53 diabetic neuropathic pain 53 imipenem 53 Lubiprostone 53 REMICADE 53 placebo controlled Phase III 53 ALIMTA 53 oral Xeloda 53 dacetuzumab 53 Inhalation Solution 53 Rebetol 53 tinidazole 53 belatacept 53 PRTX 53 Fibrillex TM 53 amphotericin B 53 VAPRISOL 53 DAVANAT ® 53 hematological cancers 53 CR# vcMMAE 53 Xeloda capecitabine 53 Campath 53 previously untreated follicular 53 Orphan Drug status 53 Daclizumab 53 Dabigatran etexilate 53 metastatic CRC 53 methotrexate 53 STELARA ™ 53 STELARA TM 53 DAVANAT 53 paclitaxel poliglumex 53 TNF inhibitor 53 placebo controlled clinical 53 Pegintron 53 FavId 53 Exemestane 53 Phase IIa trial 53 febrile neutropenia 53 Copegus ribavirin 53 Quinamed 53 Sanvar R 53 afatinib 53 raltegravir 53 paclitaxel 53 SCCHN 53 Rhucin ® 53 LEVADEX 53 immunomodulatory therapy 53 Protopic 53 OvaRex ® MAb 53 NVA# 53 Celgene Revlimid 53 Rexin G 53 cinacalcet 53 dalbavancin 53 IMC A# 53 THALOMID R 53 oral prodrug 53 cisplatin 53 Zavesca r 53 etoposide 53 XYOTAX 53 HoFH 53 C1 INH 53 efficacy tolerability 53 EndoTAG TM -1 53 ularitide 53 ABILIFY 53 R adalimumab 53 ABILIFY R 53 Abbott HUMIRA 53 pemetrexed Alimta 53 echinocandin 53 Folotyn 53 Entereg 53 Gleevec resistant 53 IXEMPRA 53 cyclophosphamide 53 Rasilamlo 53 platinum refractory 53 sunitinib Sutent 53 Sutent 53 Moxifloxacin 53 refractory Hodgkin lymphoma 53 deferiprone 53 DexaSite 53 cell lymphoma CTCL 53 ambrisentan 53 Plicera 53 sNDA 53 Fabry Disease 53 VEGF Trap 53 Hepatocellular Carcinoma HCC 53 erlotinib Tarceva 53 vernakalant 53 huN# DM1 53 Vidofludimus 53 paclitaxel Taxol R 53 HuMax CD# 53 mifamurtide 53 otelixizumab 53 placebo controlled clinical trials 53 DR Cysteamine 53 MyVax R 53 Zevalin 53 fluconazole 53 lamivudine 53 roflumilast 53 myelodysplastic syndrome MDS 53 Rasilez Tekturna 53 Rivaroxaban 53 Rasilez 53 heterozygous FH 53 proteasome inhibitor bortezomib 53 Oracea 53 APTIVUS r 53 SAPHRIS 53 Omacetaxine 53 oritavancin 53 PRISTIQ 53 Phase 1b clinical 53 amifostine 53 azathioprine 53 chemotherapeutic regimen 53 AMEVIVE 53 Sycrest 53 Zerenex 53 orphan medicinal product 53 Eribulin 53 Archexin 53 remission induction 53 oral diclofenac 53 BENLYSTA ® 53 Vidaza azacitidine 53 phase Ib 53 ProSavin 53 CYC# 53 basiliximab 53 KRAS mutations occur 53 Dapagliflozin 53 relapsing forms 53 MAA submission 53 inhaled iloprost 53 Restanza 53 PROSTVAC TM 53 Remodulin 52 telaprevir 52 Campath ® 52 Sudhir Agrawal D.Phil 52 Aflibercept